(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

Ergocristine; LC-APCI-QTOF; MS; NEGATIVE

Ergocristine; LC-APCI-QTOF; MS; POSITIVE

Ergocristine; LC-ESI-ITFT; MS2; CE: 10; R=17500; [M+H]+

Ergocristine; LC-ESI-ITFT; MS2; CE: 20; R=17500; [M+H]+

Ergocristine; LC-ESI-ITFT; MS2; CE: 30; R=17500; [M+H]+

Ergocristine; LC-ESI-ITFT; MS2; CE: 40; R=17500; [M+H]+

Ergocristine; LC-ESI-ITFT; MS2; CE: 55; R=17500; [M+H]+

Ergocristine; LC-ESI-QTOF; MS; NEGATIVE

Ergocristine; LC-ESI-QTOF; MS; POSITIVE